Is EU legal regulation stifling the growth of medical 3D printing?
Medical 3D printing, also known as additive manufacturing, is the use of 3D printing technology to create medical devices, implants and prosthetics.
Jul 17, 2024
0
0
Medical 3D printing, also known as additive manufacturing, is the use of 3D printing technology to create medical devices, implants and prosthetics.
Jul 17, 2024
0
0
Inequitable access to COVID-19 vaccines has turned out to be the catastrophic moral failure the World Health Organization's director-general warned about at the beginning of 2021.
Aug 30, 2022
0
13
When will COVID-19 vaccines be widely available globally?
May 13, 2021
0
1
COVAX, the global initiative to coordinate the distribution of COVID-19 vaccines in an equitable way, is crucial for bringing the pandemic under control.
Apr 13, 2021
1
0
The World Trade Organisation has agreed to extend a waiver that allows poor countries to copy patented medicines. The waiver, which was due to expire in January 2016, has now been extended to 2033.
Nov 25, 2015
1
45
A free trade pact being negotiated by the U.S. and 11 Asia-Pacific nations will impose aggressive intellectual property rules that could restrict access to affordable medicines in developing nations, health activists warned ...
Jul 3, 2013
0
0
A US-led Pacific free trade pact faces further delays as a row between Big Pharma and activists supporting access to generic drugs erupts ahead of an October deadline, officials say.
Mar 10, 2013
1
0
India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important precedent for getting inexpensive ...
Mar 5, 2013
3
0
Pharmaceutical giant Bayer AG on Wednesday said it was "disappointed" with an Indian ruling that allows a local firm to produce a cheaper copy of its patented drug Nexavar for liver and lung cancer.
Sep 26, 2012
0
0
Biotechnology industry officials are warning that a US Supreme Court ruling on patent rights this week could have a chilling effect on the development of personalized medicine.
Mar 21, 2012
1
0